Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives

Satadeepa Kal1, Sumana Mahata2, Suborno Jati3

  • 1Department of Medicine, University of California San Diego, La Jolla, CA, USA.

Peptides
|December 31, 2023
PubMed

Insights

Mitochondrial-derived peptides (MDPs) are novel microproteins from mitochondrial DNA that regulate diabetes. These peptides show conserved sequences, highlighting their evolutionary importance in metabolic health.

Area of Science:

  • Mitochondrial biology
  • Molecular genetics
  • Endocrinology

Background:

  • Mitochondrial-derived peptides (MDPs) are newly identified bioactive microproteins encoded by mitochondrial DNA (mtDNA).
  • Three main types exist: Humanin (HN), MOTS-c, and SHLP1-6, encoded by specific ribosomal RNA genes on mtDNA.
  • Mitochondrial genetic codes differ from nuclear DNA, utilizing unique start and stop codons and coding assignments.

Purpose of the Study:

  • To review the role of MDPs in regulating diabetes mellitus, including Type 1 (T1D), Type 2 (T2D), and gestational diabetes.
  • To explore the evolutionary conservation of MDP amino acid sequences.
  • To highlight MDPs' therapeutic potential in metabolic diseases.

Main Methods:

  • Review of existing literature on MDPs, mtDNA genetics, and diabetes.
  • Analysis of genetic codes and gene locations for MDPs within mtDNA.
  • Examination of studies investigating MDP function in diabetes models.

Main Results:

  • MDPs, including HN, MOTS-c, and SHLP peptides, are encoded on both heavy and light strands of mtDNA.
  • These peptides have demonstrated potential in attenuating pathologies associated with T1D, T2D, and gestational diabetes.
  • Amino acid sequences of MDPs exhibit significant evolutionary conservation.

Conclusions:

  • MDPs represent a critical link between mitochondrial function and metabolic regulation, particularly in diabetes.
  • The evolutionary conservation of MDPs underscores their fundamental biological roles.
  • Further research into MDPs could lead to novel therapeutic strategies for diabetes treatment.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
325
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.8K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
2.6K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
188
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
941